Quote | SOPHiA GENETICS SA (NASDAQ:SOPH)
Last: | $4.60 |
---|---|
Change Percent: | 0.64% |
Open: | $4.63 |
Close: | $4.60 |
High: | $4.64 |
Low: | $4.3522 |
Volume: | 162,369 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | SOPHiA GENETICS SA (NASDAQ:SOPH)
India-Based Dhiti Omics is Now Live on SOPHiA DDM™ PR Newswire The diagnostics company has implemented the SOPHiA DDM ™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland , July 4, 2024 /PRNewswire/ -- SO...
BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that its annual general meeting of shareholders (the “ AGM ”) was held at the Company&...
Message Board Posts | SOPHiA GENETICS SA (NASDAQ:SOPH)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
India-Based Dhiti Omics is Now Live on SOPHiA DDM™ PR Newswire The diagnostics company has implemented the SOPHiA DDM ™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland , July 4, 2024 /PRNewswire/ -- SO...
BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that its annual general meeting of shareholders (the “ AGM ”) was held at the Company&...
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application PR Newswire Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland , June 24, 2024 ...